Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Special Report
Your complete PBS reform rundown
The vast PBS reform package released by Health Minister Sussan Ley imposes changes on all parts of the PBS supply chain. Here's your guide to each initiative.
Working Life
Tips and tricks to keep your CV in shape
Many pharma industry professionals choose to work their entire careers in the sector so specialist CVs are essential for employment success, and with high demand for good candidates, recruiters say it pays to keep yours up to date.
Approvals Action
Competition grows for $38m Alimta
Competition for Eli Lilly's $38m cancer drug Alimta is growing with four generic companies having registered rival brands on the ARTG although Lilly still has the sole PBS listing.
Special Report
What will a 'sustainable' PBS look like?
Health Minister Sussan Ley says she must fashion a 'sustainable' PBS if new medicines are to be listed in future. Her choices are many experts say but few will please pharma.
PBS Top Five
Infectious diseases - a market in suspension
The infectious diseases market is expected to surge once new hep C treatments such as Sovaldi and Harvoni are PBS listed but right now it looks like prescribers are holding back.